Data / Drug companies / Albuterol sulfate
Albuterol sulfate: 46 companies and 116 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Albuterol sulfate is listed in the FDA National Drug Code Directory by 46 companies, with 116 products in commercial distribution. 92 of the products (79.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; aerosol, metered; inhalant, and the newest product started marketing on April 22, 2026.
The request: Get every company that lists albuterol sulfate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 46
- Products
- 116
- Generic (ANDA) products
- 92 (79.3%)
- Application numbers
- 25
- Routes
- Respiratory (inhalation), Oral
- Brand names
- Ventolin Hfa, Albuterol Sulate Hfa, ProAir Digihaler, Albuterol, ProAir RespiClick
- openFDA record search
- api.fda.gov
Companies that list albuterol sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 10 | aerosol, metered; solution | Generic drugs (ANDA) | August 6, 2024 |
| A-S Medication Solutions | 8 | aerosol, metered; inhalant | Generic drugs (ANDA) | August 25, 2020 |
| Preferred Pharmaceuticals Inc. | 8 | aerosol, metered; inhalant | Generic drugs (ANDA) | October 13, 2025 |
| Remedyrepack Inc. | 8 | aerosol, metered; solution | Generic drugs (ANDA) | December 3, 2025 |
| Chartwell RX, LLC | 7 | solution; tablet | Generic drugs (ANDA) | March 31, 2010 |
| Asclemed USA, Inc. | 5 | aerosol, metered; solution | Generic drugs (ANDA) | November 30, 2021 |
| Nephron Pharmaceuticals Corporation | 4 | solution | Generic drugs (ANDA) | March 31, 2010 |
| Proficient Rx LP | 4 | aerosol, metered; solution | Generic drugs (ANDA) | June 11, 2021 |
| Rising Pharma Holdings, Inc. | 4 | solution | Generic drugs (ANDA) | April 14, 2025 |
| Ritedose Pharmaceuticals, LLC | 4 | solution | Generic drugs (ANDA) | March 24, 2025 |
| Sportpharm LLC | 4 | aerosol, metered; solution | Generic drugs (ANDA) | November 30, 2021 |
| HF Acquisition Co LLC, DBA HealthFirst | 3 | aerosol, metered; solution | Generic drugs (ANDA) | August 18, 2020 |
| Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 3 | solution | Generic drugs (ANDA) | April 20, 2020 |
| Advanced Rx of Tennessee, LLC | 2 | aerosol, metered | Authorized generics (NDA) | September 7, 2023 |
| American Health Packaging | 2 | solution; inhalant | Generic drugs (ANDA) | January 18, 2023 |
| Aurobindo Pharma Limited | 2 | solution | Generic drugs (ANDA) | April 20, 2020 |
| Cardinal Health 107, LLC | 2 | solution | Generic drugs (ANDA) | January 16, 2023 |
| Cipla USA Inc. | 2 | aerosol, metered; inhalant | Generic drugs (ANDA) | April 22, 2026 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | December 5, 1989 |
| Ingenus Pharmaceuticals, LLC | 2 | solution | Generic drugs (ANDA) | November 1, 2024 |
| Proficient Rx LP | 2 | solution; aerosol, metered | Generic drugs (ANDA) | June 9, 2006 |
| Proficient Rx LP | 2 | aerosol, metered | Authorized generics (NDA) | November 30, 2021 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | December 5, 1989 |
| Teva Respiratory, LLC | 2 | inhalant; powder, metered | New drug applications (NDA) | October 4, 2019 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | September 22, 2015 |
| Amneal Pharmaceuticals NY LLC | 1 | inhalant | Generic drugs (ANDA) | December 3, 2025 |
| Armstrong Pharmaceuticals, Inc. | 1 | inhalant | Generic drugs (ANDA) | August 6, 2024 |
| Asclemed USA Inc. | 1 | solution | Generic drugs (ANDA) | September 17, 1997 |
| Aurobindo Pharma Limited | 1 | solution | Generic drugs (ANDA) | October 17, 2017 |
| Bryant Ranch Prepack | 1 | syrup | Generic drugs (ANDA) | September 6, 2019 |
| Bryant Ranch Prepack | 1 | syrup | Generic drugs (ANDA) | September 6, 2019 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | syrup | Generic drugs (ANDA) | June 26, 2007 |
| Exelan Pharmaceuticals Inc. | 1 | inhalant | Generic drugs (ANDA) | October 4, 2021 |
| GlaxoSmithKline LLC | 1 | aerosol, metered | New drug applications (NDA) | June 9, 2006 |
| Hawaii Repack, Inc. | 1 | aerosol, metered | Generic drugs (ANDA) | November 30, 2021 |
| Hikma Pharmaceuticals USA Inc. | 1 | aerosol, metered | Generic drugs (ANDA) | November 30, 2021 |
| Lupin Pharmaceuticals, Inc. | 1 | aerosol, metered | Generic drugs (ANDA) | August 25, 2020 |
| Medical Purchasing Solutions, LLC | 1 | solution | Generic drugs (ANDA) | December 5, 2011 |
| Mylan Pharmaceuticals Inc. | 1 | solution | Generic drugs (ANDA) | October 15, 2012 |
| Padagis Israel Pharmaceuticals Ltd | 1 | aerosol, metered | Generic drugs (ANDA) | February 26, 2020 |
| Prasco Laboratories | 1 | aerosol, metered | Authorized generics (NDA) | January 15, 2019 |
| Quagen Pharmaceuticals LLC | 1 | syrup | Generic drugs (ANDA) | September 6, 2019 |
| Redpharm Drug | 1 | solution | Generic drugs (ANDA) | June 11, 2021 |
| Sandoz Inc | 1 | aerosol, metered | Authorized generics (NDA) | March 15, 2021 |
| Sun Pharmaceutical Industries, Inc. | 1 | solution | Generic drugs (ANDA) | June 11, 2021 |
| Teva Pharmaceuticals USA, Inc. | 1 | aerosol, metered | Authorized generics (NDA) | January 16, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 47 | 40.5% |
| Aerosol, metered | 43 | 37.1% |
| Inhalant | 12 | 10.3% |
| Tablet | 7 | 6% |
| Syrup | 6 | 5.2% |
| Powder, metered | 1 | 0.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 92 | 79.3% |
| New drug applications (NDA) | 14 | 12.1% |
| Authorized generics (NDA) | 10 | 8.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta2-Adrenergic Agonist | 116 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.